Dow Up 0.09% Nasdaq Down 0.02%

Sinovac Biotech Ltd. (SVA)

-NasdaqGS
5.41 0.08(1.46%) Aug 27, 4:00PM EDT
Prev Close:5.49
Open:5.48
Bid:N/A
Ask:7.00 x 100
1y Target Est:9.50
Beta:0.21
Next Earnings Date:N/A
Day's Range:5.40 - 5.48
52wk Range:4.73 - 8.14
Volume:102,379
Avg Vol (3m):172,398
Market Cap:301.14M
P/E (ttm):32.01
EPS (ttm):0.17
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SVA

Comparison

Symbol% ChgMkt Cap
SVADown 1.46%301.14M
GSK116.91B
SNY144.88B

Key Statistics

Forward P/E (1 yr):60.11
P/S (ttm):4.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.04
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-11.71

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sinovac Biotech Ltd., a biopharmaceutical company, is engaged in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback